I am 34, female. At what age is the HPV vaccine given?

Hi,

Welcome to icliniq.com.

I can understand your concern.

HPV (human papillomavirus) is a common sexually transmitted infection. Certain high-risk types of HPV, especially HPV-16 and HPV-18, can cause cervical cancer by infecting cells lining the cervix. Persistent infection with these high-risk types can lead to precancerous changes in cervical cells, which, if left untreated, can progress to cervical cancer.

The HPV vaccine is most effective when given before exposure to HPV through sexual activity. It is recommended for girls and boys, ideally between the ages of 9 and 14 years. However, it can be given up to age 26 for females and 21 for males who have not been vaccinated earlier.

The HPV vaccine is highly effective in preventing infection with the most common high-risk HPV types (such as HPV-16 and HPV-18) that cause cervical cancer. It also protects against other HPV types that cause genital warts.

There are several HPV vaccines available globally.

The most widely used ones are

1. Bivalent vaccine: Protects against HPV-16 and HPV-18.
2. Quadrivalent vaccine: Protects against HPV-6, HPV-11 (which causes genital warts), HPV-16, and HPV-18.
3. Nonavalent vaccine: Protects against HPV-6, HPV-11, HPV-16, HPV-18, HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58.

The government introduced the HPV vaccine into the national immunization program in 2019, initially targeting girls aged 9 to 14 years. However, challenges such as vaccine hesitancy (delay in acceptance or refusal of vaccines despite the availability of vaccination services), logistical issues, and competing health priorities have affected vaccination rates.

Challenges to HPV vaccine uptake:

1. Awareness and education: Many people are unaware of HPV and its link to cervical cancer. There may also be misconceptions and myths surrounding the vaccine.
2. Access and availability: Ensuring the vaccine reaches remote and underserved areas poses logistical challenges.
3. Cultural and religious factors: Some communities may have cultural or religious beliefs that influence vaccine acceptance.

For those who have not been vaccinated or for older women, screening methods for early detection of cervical cancer include:

1. Pap (Papanicolaou) smear: A Pap smear (or Pap test) detects abnormal cells in the cervix before they become cancerous.
2. HPV DNA (DNA of human papillomaviruses) test: This test detects the presence of high-risk HPV types in cervical cells.
3. Visual inspection with acetic acid (VIA): A simple test where the cervix is inspected after applying acetic acid to identify precancerous lesions.

There are ongoing efforts to raise awareness about HPV and promote vaccination through:

1. Health education campaigns: Using media, community outreach, and healthcare provider training to educate about HPV, cervical cancer, and the benefits of vaccination.
2. Integration with immunization programs: Including HPV vaccination in routine immunization schedules to improve access.

So, in a nutshell, HPV is a significant factor in cervical cancer development, but vaccination and early detection through screening can greatly reduce its impact. Efforts are underway to improve HPV vaccine uptake and cervical cancer screening rates through education, integration with healthcare services, and targeted public health initiatives. Encouragingly, increased awareness and continued support can lead to better prevention and management of cervical cancer in the country.

I hope that you get your answer.

Please let me know if you need any help.